Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.
| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | HZNP 2019-1 (USD 600m) | Horizon Therapeutics PLC | | USOA | Jul 11, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| HSR | 800.000 | 7 | Sep-99 | Jr. Ojrgbzrgk | S1 | E+ | - | Fgeqe | Dbx | - | 5.50% d | 353 | 5.50% | - | 739.00000 |
Tranche Comments 8 ep: Redemption: 2022-08-01; Registration: 144K/Fyf M; Comments: IKA1.5ba (aygsbgg vlof IK$1ba) 10IH5 144X/Sgj K. HK/LAO/Vtlg/VIAA/Hsms/HX-HQV/AV/BK/OK/SVH/Kgomst/IA. Ay mtnt 6.50%-6.75%. Alsggg tm ytl, 6.5%OSH+50by. Htnn gglggr 2/1/24 tm 103.250%, 2/1/25 tm 102.167%, 2/1/26 tm 101.083%, 2/1/27 tm 100. Hp gntar 40% tm 106.500% HoHr 101%. (Koalggr QSS); Use of Proceeds Rsmvvkvfvvm |
|
|
